Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
PaperCitations, authors & open-access status
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 408 citations, 2012 year and closed oa status.
408
Citations
2012
Year
closed
OA Status